{"name":"Direct Therapeutics","slug":"direct-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxONEhSRzFJTWxLWWYzTHhmN0dqcXBCa0lWRHJ2YmF2UERocjgxaG15ZHB2aUVZbUhpdTFsMWtOZXNiYzNRTEpmNGZqY19uekpwb25OaDd0MWlkS25SWS10c0NSNGhZdExvQWhsNVU4clppT21jdGN6dDN6R1dnd1R1SGdhczhycWN4dlJFRUJlc0lFeU5OTllRbkJqenBkT0JReWVUSmcxX1JjSWdhMU5DNkZCdUVvcHN4bHJZa0l5RlEteFp2bEdaNVdYTkl4Zw?oc=5","date":"2026-04-02","type":"pipeline","source":"PR Newswire","summary":"Hoth Therapeutics Announces Closing of $2.0 Million Registered Direct Offering - PR Newswire","headline":"Hoth Therapeutics Announces Closing of $2.0 Million Registered Direct Offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2026-03-03","type":"pipeline","source":"Business Wire","summary":"Seaport Therapeutics and Monash Institute of Pharmaceutical Sciences Awarded up to $15 Million from ARPA‑H to Advance Seaport’s GlyphCele™, the First Oral Therapeutic Designed to Restore Gut Lymphatic","headline":"Seaport Therapeutics and Monash Institute of Pharmaceutical Sciences Awarded up to $15 Million from ARPA‑H to Advance Se","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNS2pBVGYzQUhKaWdBYWRVaFJCZm03UHN6YjNiWUwzV0JHTUxKSThpdnVxNlJYd0VVOHp1TzkzMkFMX0pPaE4ySFdNdzM3OEZINmtaOUR1RndlaTM5RGc0NllWTGNFcWNSMldlbUIwMzRlMjBwMF9fUHdEbURybVRiR290WURBTm9IbXA5WW82VU9sSXBxRXQ1alkzT1dWRzZpeGZ1aUlTLXlkNlYtcEdsQU1ISDdOZlVIRF9F?oc=5","date":"2026-02-20","type":"regulatory","source":"Buchanan Ingersoll & Rooney","summary":"Corcept Therapeutics v. Teva Pharmaceuticals: Going Outside the Label To Show No Direct Infringement - Buchanan Ingersoll & Rooney","headline":"Corcept Therapeutics v. Teva Pharmaceuticals: Going Outside the Label To Show No Direct Infringement - Buchanan Ingersol","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPSHlTaUJacDVWTzR6U2VWSXFIU1hzeU9fN3pTM2lZMncyaTNPbzJMTUk4anhJTmJyN29TZTYtelQ0Tm1OTUtWVmNzbWxEQldkYXpJVlU4YS1jYXl1N2pjVURkeTZVczBHY1JZaWphNVRveng2cWdxeGdCeldham91VUtBNnZCNFlyeENUalpCay1mYzg?oc=5","date":"2026-02-20","type":"pipeline","source":"kffhealthnews.org","summary":"Should Drug Companies Be Advertising to Consumers? - kffhealthnews.org","headline":"Should Drug Companies Be Advertising to Consumers?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOQ3JLQjQwcHBlUVFfMV9BYUlVRV8tMlJFOWNNYUo5Z1cyWERIR1hnR0dhNldmOFNjeUlUVXJVQnp5Mm12Q1NEN1Zxay1kcHJMYUhoM1YycFl0Qnh2TVZrOFRmUFp2b2FiRHdIblZzR2NQZ1N5MGVkdng2SUdQSXotQ2FtVllaekdiVjhybXNzdzVWOHpnTkdKdm1lSDhyQ0hwTnlkWndONVZ1UQ?oc=5","date":"2025-12-12","type":"deal","source":"Fierce Biotech","summary":"Obesity biotech Zealand seeks partners to 'take therapies directly to the brain' - Fierce Biotech","headline":"Obesity biotech Zealand seeks partners to 'take therapies directly to the brain'","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQQThhVEdORFlqbFlGdThmTExKVXZtenlfdUx6M0VPYTRmZ3RQSVRvcXJSNWNmOFhyTTVud25HTjRVaTA0Yjdta1VwTjAwVUFPQjgxaXlCNnVPSThyOVBFZGhjempzN0JUYmtYUkJSYTJqdHF0UDN4ZTZYVXZKUE1GVkQ5R0FzTHlKaTZrazFNdVNrZjR6Qld3cWdqdURGR2hy?oc=5","date":"2025-11-25","type":"pipeline","source":"Seeking Alpha","summary":"Polaryx Therapeutics Seeks Direct Listing For Shareholders (PLYX) - Seeking Alpha","headline":"Polaryx Therapeutics Seeks Direct Listing For Shareholders (PLYX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQQ3V3TEEwT21DbjR1NkNfTXc1TldsRTgxS2J5dDJoWkxDd05qb1FfdFVaNnBPM0Q5ZG01ZDR4em5uUl9KdE1rc1hTdHdjbVlwTHpjU0daMFU0RjAzMVFqUXpocllicDFZV2FYT0JyQm1oSk5FbFpjSkpocGxIWWYyNVpiUmE4VFFyMEVrbHpMWkNnYjVaRTh5WXFwNng?oc=5","date":"2025-11-07","type":"pipeline","source":"Pharmaceutical Commerce","summary":"Will Pharma’s Direct-to-Patient Push Disintermediate Wholesalers? - Pharmaceutical Commerce","headline":"Will Pharma’s Direct-to-Patient Push Disintermediate Wholesalers?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxQNFNjdDVOY1g4TUhaWFo0WDdoMTlVT2JfZU5hb19FakxVc1lQRlNMa2xHanZxdGptYk95NU9NdWtxM01NMkxEQnhCWWNUbXk2TjA0UE1WZlRKR2xFbDcwRVBZNlNLazhnUkRKRDcxVmlVQ0U0NHNONnhOVVRXXzVqNC1UbTM1dklMYjVGQkVtNDVEVEF6bEtQOC1Pd2p5NnJkU3N0OWdOcUJJY09JcVB5bkNrWnhrUUlZZDRfUGhkaUNsd0R1Z1Z5XzJJaWxIbjVHUzc3TnpHZUJ0ZW1IOWJfOHBTVnY1WHh6T2gyaVlXb1JTdjVSbUtrM1oyN0RxTXl5dzJ2MVhKeUs3Tk1iWFNDOVQzVDlMbFhTRldqM0l2Tk00TW94RWhUUWZoZjM3b0RINHpZdDlpZVVDdm0y?oc=5","date":"2025-10-23","type":"trial","source":"Business Wire","summary":"Circle Pharma Unveils First Preclinical Data from Cyclin D1 Program at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Business Wire","headline":"Circle Pharma Unveils First Preclinical Data from Cyclin D1 Program at the AACR-NCI-EORTC International Conference on Mo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNTGhoRFVHcGtLa2p6NGJDN0Z0Q0RUOXFuLUJoNVJRSjR5dDdKcjFOZUhNYkgxY2hRZk1iVVNmRC11STdkMklrTnZseVAzZ2g5Yml6WXJ4NzBVdEtOVDk4UTBkS0EwWTJzQzZmOWxrQXR4aHFfWGN3TDlVbVFsY1JPNWx5ZEhLd0pFN3FZblZIOWo2dHpMUU1TYXRGbjZWVU1rWWV4TjJMWVZmN09OeExXWHc3MUl6YTA0YTdXRU5rcUd0TFE?oc=5","date":"2025-09-30","type":"pipeline","source":"BioXconomy","summary":"PHIL unveils direct-to-patient 2.0 platform for pharma access and affordability - BioXconomy","headline":"PHIL unveils direct-to-patient 2.0 platform for pharma access and affordability","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOYXBEcllfQ0hGeUVHQWY1UnRxUFREY1RMY1JxR08tQ0RrVkU2aXBlaFJHUDJJUXVDUmx6OWZHaFlkQ09jTXU0X2UtS3Y1VkF6My1jbFY2Y1Q5b0Vhd3FvWTcyNVNCSDN5WjFPSFRnTTgtVmRGaFdhVTBfQy02cmRyN2dCSmh5c3E4WWJuYVRwM3BtY3g4TVdMTmpvSHd6d2x5aWQ5OXZSd0NrdmkyZnBoT2R6TFFfeXlZRERr?oc=5","date":"2025-09-25","type":"pipeline","source":"Fierce Pharma","summary":"Direct-to-patient programs are in the works at 94% of pharmas, set to become 'standard practice': survey - Fierce Pharma","headline":"Direct-to-patient programs are in the works at 94% of pharmas, set to become 'standard practice': survey","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPMzB4VHNVZ0ZGaTA4WVJ4OFJsenlOQmJmM1luUEJfZXRuWlhrLWdKU1FYUkFyMkpwUDFKQmFST2U1X1diQ0I3WXRjTnFtUHMtb2RfcTRUSW5CdHJWX0pUWW5Bd21wUS1mT0otTm11RUJtS1dPMFdScGNIakJqdHhyUnkxQzBpVzJ6VUlteXJjZWZLSmd4VW1WMXlWOW52UQ?oc=5","date":"2025-09-23","type":"pipeline","source":"Life Science Leader","summary":"Pharma Direct-To-Patient 2.0: From Experiment To Imperative - Life Science Leader","headline":"Pharma Direct-To-Patient 2.0: From Experiment To Imperative","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9SZmVYd0ZUaXBJSzJYZkFEUVE2ZzdEY2lvOGdBSmtsOHZyRDNnVFZCakpZdkhJQURVME1ta3p2bzBKTG1VZmowdU1FZGFGSEhObEJB?oc=5","date":"2025-07-24","type":"pipeline","source":"FirstWord Pharma","summary":"Roche considering direct-to-patient sales in US to bypass intermediaries - FirstWord Pharma","headline":"Roche considering direct-to-patient sales in US to bypass intermediaries","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}